MARTORANA, ALESSANDRO

MARTORANA, ALESSANDRO  

Dipartimento di Medicina dei sistemi  

Mostra records
Risultati 1 - 20 di 104 (tempo di esecuzione: 0.019 secondi).
Data di pubblicazione Titolo Autore(i) Tipo File
23-set-2014 "Homotaurine induces measurable changes of short latency afferent inhibition in a group of mild cognitive impairment individuals" Martorana, A; Di Lorenzo, F; Manenti, G; Semprini, R; Koch, G Articolo su rivista
23-apr-2015 A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus Schirinzi, T; Sancesario, G; Ialongo, C; Imbriani, P; Madeo, G; Toniolo, S; Martorana, A; Pisani, A Articolo su rivista
1-giu-2010 Abeta1-42 Detection in CSF of Alzheimer's disease is influenced by handling temperature: indication of reversible Abeta1-42 aggregation? Sancesario, G; Esposito, Z; Nuccetelli, M; Sorge, Rp; Martorana, A; Federici, G; Bernardi, G; Bernardini, S; Sancesario, G Articolo su rivista
15-giu-2003 Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway Pisani, A; Bonsi, P; Centonze, D; Martorana, A; Fusco, F; Sancesario, G; De Persis, C; Bernardi, G; Calabresi, P Articolo su rivista
15-ott-2005 AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis Stefani, A; Bernardini, S; Panella, M; Pierantozzi, M; Nuccetelli, M; Koch, G; Urbani, A; Giordano, A; Martorana, A; Orlacchio, A; Federici, G; Bernardi, G Articolo su rivista
1-gen-2005 AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis. Stefani, A; Bernardini, S; Panella, M; Pierantozzi, M; Nuccetelli, M; Koch, G; Urbani, A; Giordano, A; Martorana, A; Orlacchio, A; Federici, G; Bernardi, G Articolo su rivista
1-gen-2008 Adult polyglucosan body disease: Proton magnetic resonance spectroscopy of the brain and novel mutation in the GBE1 gene Massa, R; Bruno, C; Martorana, A; De Stefano, N; Van Diggelen, O; Federico, A Articolo su rivista
1-gen-2013 Ageing as a Trait de Union between diabetes and dementia for frailty Semprini, R; Ragonese, M; Poggi, M; Franze, A; Martorana, A Articolo su rivista
1-gen-2011 Altered dopamine modulation of LTD-like plasticity in Alzheimer’s disease patients Koch, G; Esposito, Z; Codecà, C; Mori, F; Kusayanagi, H; Monteleone, F; Di Lorenzo, F; Bernardi, G; Martorana, A Articolo su rivista
1-gen-2017 Alzheimer’s disease and the routine clinical use of CSF biomarkers Martorana, A Articolo su rivista
1-ago-2013 Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track? Esposito, Z; Belli, L; Toniolo, S; Sancesario, G; Bianconi, C; Martorana, A Articolo su rivista
1-feb-2018 Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease Schirinzi, T; Di Lorenzo, F; Sancesario, G; Di Lazzaro, G; Ponzo, V; Pisani, A; Mercuri, N; Koch, G; Martorana, A Articolo su rivista
1-gen-2011 Assessment of Optic Nerve Head and Retinal Nerve Fibre Layer Changes and Evaluation of Frequency of Glaucoma in Patients with Alzheimer's Disease Cesareo, M; Greco, P; Martucci, A; Chiarucci, M; Martorana, A; Sorge, R; Sancesario, G; Cerulli, L; Nucci, C Intervento a convegno
15-giu-2017 Assessment of serum uric acid as risk factor for tauopathies Schirinzi, T; Di Lazzaro, G; Colona, Vl; Imbriani, P; Alwardat, M; Sancesario, Gm; Martorana, A; Pisani, A Articolo su rivista
1-gen-2015 Association between alzheimer's disease and glaucoma: A study based on heidelberg retinal tomography and frequency doubling technology perimetry Cesareo, M; Martucci, A; Ciuffoletti, E; Mancino, R; Cerulli, A; Sorge, Rp; Martorana, A; Sancesario, G; Nucci, C Articolo su rivista
1-gen-2006 Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity. Demarch, Z; Giampa, C; Patassini, S; Martorana, A; Bernardi, G; Fusco, F Articolo su rivista
1-ago-2010 Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease? Martorana, A; Esposito, Z; Koch, G Articolo su rivista
1-giu-2021 Brain energy metabolism and neurodegeneration: hints from CSF lactate levels in dementias Bonomi, Cg; De Lucia, V; Mascolo A. P. b, Am; Motta, C; Scaricamazza, E; Sallustio, F; Mercuri, Nb; Koch, G; Martorana, A Articolo su rivista
1-gen-2018 Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study Chiaravalloti, A; Barbagallo, G; Ricci, M; Martorana, A; Ursini, F; Sannino, P; Karalis, G; Schillaci, O Articolo su rivista
1-giu-2019 Brain metabolic patterns in patients with suspected non-Alzheimer’s pathophysiology (SNAP) and Alzheimer’s disease (AD): is [18F] FDG a specific biomarker in these patients? Chiaravalloti, A; Barbagallo, G; Martorana, A; Castellano, Ae; Ursini, F; Schillaci, O Articolo su rivista